Alexander   V.  Kazansky

Associate Professor  

Office: BBRHB 1.122
Phone: (956) 882-5780
Email: alexander.kazansky@utrgv.edu

Dr. Alexander V. Kazansky

EMPLOYMENT 2014-present Associate Professor, Dept. of Health and Biomedical Sciences, University of Texas Rio Grande Valley (UTRGV) 2011-2014 Associate Professor, Dept. Biomedicine, University of Texas Brownsville (UTB) 2006-2011 Associate Professor, Department of Biological Science, University of Texas at Brownsville, 80 Fort Brown, LHSB, Brownsville, Texas 2006-present Adjunct Associate Professor, Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas 2003-2006 Assistant Professor, Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas 1997-2003 Faculty Appointment to Instructor, Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas 1992-1997 Postdoctoral Fellow, Department of Cell Biology, Baylor College of Medicine, Houston, Texas 1990-1992 Research Associate, Laboratory of Molecular Genetics of Cell Differentiation, Institute of Gene Biology, Moscow, Russia 1985-1990 Graduate Student, Institute of General Genetics and Koltzov Institute of Developmental Biology, Moscow, Russia EDUCATION 1992-1997 Postdoctoral Fellow, Department of Cell Biology, Baylor College of Medicine, Houston, Texas 1990 Ph.D. Molecular Biology Koltzov Institute of Developmental Biology, Moscow, Russia. 1985 M.S. Biochemistry Lomonosov Institute of Fine Chemical Technology, Moscow, Russia.





Selected Publications


  • Alexander Kazansky. "Novel nanotechnology approach to target cancer- Switch from Proto-Oncogene to Tumor Suppressor.," Edinburg, TX: Inaugural Research Symposium of the UTRGV School of Medicine, UTRGV, August 2017: 16.

  • Aleksandra Shchelkunova, Boris Ermolinsky, Meghan Boyle, Ivan Mendez, Michael Lehker, Karen Martirosyan, and Alexander Kazansky. "Tuning of Alternative Splicing - Switch From Proto-Oncogene to Tumor Suppressor," International Journal of Biological Sciences 9, no. 1 (2013): 45-54.

  • Aleksandra Shchelkunova, Boris Ermolinsky, Meghan Boyle, Ivan Mendez, Michael Lehker, Karen Martirosyan, and Alexander Kazansky. "Tuning of Alternative Splicing - Switch From Proto-Oncogene to Tumor Suppressor," International Journal of Biological Sciences 9, no. 1 (2013): 45-54.

  • Alexander Kazansky, Khalid Aada, Karen Martirosyan, "Novel nanotechnology approach to target cancer disease by switching an alternative splicing," Brownsville: TS APS Annual Fall Meeting (October (4th Quarter/Autumn) 2013).

  • Alexander Kazansky, Mkhitar Hobosyan, Karen Martirosyan, "Nanoenergetic composite based on I2O5/Al for biological agent defeat," Proceedings of Nano Science and Technology Institute 3, (2012): 599-602.

  • A Liopo, A Conjusteau, D Tsyboulski, Boris Ermolinsky, Alexander Kazansky, and A Oraevsky. "Biocompatible Gold Nanorod Conjugates for Preclinical Biomedical Research.," Journal of nanomedicine & nanotechnology S2, (August 2012).

  • Alexander Kazansky. "STAT5 and Prostate Cancer.," IMPACT – Innovative Minds in Prostate Cancer Today (2007): 128.

  • Alexander Kazansky, D Spencer, and N Greenberg. "Activation of signal transducer and activator of transcription 5 is required for progression of autochthonous prostate cancer: evidence from the transgenic adenocarcinoma of the mouse prostate system.," Cancer research 63, no. 24 (December 2003): 8757-62.

  • Alexander Kazansky and J Rosen. "Signal transducers and activators of transcription 5B potentiates v-Src-mediated transformation of NIH-3T3 cells.," Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 12, no. 1 (January (1st Quarter/Winter) 2001): 1-7.

  • Alexander Kazansky, E Kabotyanski, S Wyszomierski, M Mancini, and J Rosen. "Differential effects of prolactin and src/abl kinases on the nuclear translocation of STAT5B and STAT5A.," The Journal of biological chemistry 274, no. 32 (August 1999): 22484-92.



Selected Grants and Fellowships


  • Alexander Kazansky. Acquisition of a Scanning Electron Microscope (SEM) for Multidisciplinary Research, Teaching and Outreach in the Rio Grande Valley, Department of Defense, $433,500.00 (2014 - 2014)

  • Alexander Kazansky. Novel nanotechnology approach to target prostate cancer., NIH, $316,000.00 (2009 - 2014)

  • Alexander Kazansky. Functional Imaging of Prostate Cancer with targeted contrast agents., UTB, $5,000.00 ( 2012)

  • Alexander Kazansky. MRI- Consortium: Acquisition of Cryogen-free Cryocooler-based Physical Property Measurement System to Support Transformative Device and Materials Research in the Rio Grande Valley, NSF, $437,970.00 ( 2011)

  • Alexander Kazansky. New approach to target prostate cancer., The University of Texas at Brownsville and Texas Southmost College., $15,000.00 ( 2009)

  • Alexander Kazansky. Developing Biomedical Research Infrastructure at UTB/TSC, NIH, $608,999.00 ( 2009)

  • Alexander Kazansky. Prostate Cancer Research Program, Department of Defense, U.S. Army Medical Research and Materiel Command., $22,500.00 (2003 - 2006)

  • Alexander Kazansky. Hormonal Regulation of Breast Cancer , NIH, $1,000,000.00 (1997 - 2002)



Selected Presentations


  • Alexander Kazansky. "Novel nanotechnology approach to target cancer- Switch from Proto-Oncogene to Tumor Suppressor.," Annual summit on Cell Signaling and Cancer Therapy , Chicago, USA (September 2017)

  • Alexander Kazansky, Jose Vega, "Novel nanotechnology approach to target cancer- Switch from Proto-Oncogene to Tumor Suppressor.," Inaugural Research Symposium of the UTRGV School of Medicine, UTRGV, Edinburg, TX (August 2017)

  • Alexander Kazansky. "Novel nanotechnology approach to target cancer- Switch from Proto-Oncogene to Tumor Suppressor.," Inaugural Research Symposium of the UTRGV School of Medicine., UTRGV, Edinburg, TX (August 2017)

  • Marcus Medrano, Boris Ermolinsky, and Alexander Kazansky. "New approach to alternative splicing-switch from proto-oncogene to tumor suppressor," UTRGV, (2016)

  • Merrixell Perramon Cotominas , Anna , Kuklina , Gabriel Gonzales, Boris Ermolinsky, and Alexander Kazansky. "Novel nanotechnology approach to tune up an alternative splicing – switch from proto-oncogene to tumor suppressor. ," UTRGV, UTRGV (2016)

Current Courses

BMED 1107 1BR - Intro Immunology:
Syllabus
Course Evaluations
Textbooks
BMED 1106 3BR - Intro to Medical Microbiology:
Syllabus
Course Evaluations
Textbooks
BMED 4290 01 - Med Immunology:
Syllabus
Course Evaluations
Textbooks
BMED 1106 1BR - Intro to Medical Microbiology:
Syllabus
Course Evaluations
Textbooks
BMED 1106 2BR - Intro to Medical Microbiology:
Syllabus
Course Evaluations
Textbooks
BMED 1107 3BR - Intro Immunology:
Syllabus
Course Evaluations
Textbooks
BMED 1107 2BR - Intro Immunology:
Syllabus
Course Evaluations
Textbooks

Previous Courses